Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2007 Nov 16;21(6):375–381. doi: 10.1002/jcla.20202

Genetic analysis of Indian subjects with clinical features of possible type IIa hypercholesterolemia

Altaf A Kondkar 1, Kappiareth G Nair 1, Tester F Ashavaid 1,✉
PMCID: PMC6649063  PMID: 18022922

Abstract

We performed genetic analysis in 55 patients with clinical features of possible type IIa hypercholesterolemia and 76 normolipemic healthy subjects for mutations and polymorphisms in the low‐density lipoprotein (LDL) receptor (LDLR), apolipoprotein B‐100 (APOB), apolipoprotein E (APOE), and hepatic lipase (LIPC) genes to elucidate the important genetic factors that can influence cholesterol levels in our population. None of the subjects showed mutations in part of exon 26 of the APOB gene, whereas two class 5 mutations were identified in exon 9 of the LDLR gene. First, an E387K mutation was observed in a Gujarati family in which both the parents were heterozygous for the mutation. Second, a L393R mutation was observed in a 38‐year‐old female. We found no correlation between LIPC −514C/T genotypes and cholesterol levels whereas the apoε4 allele frequency was significantly higher in cases and the apoE4 genotype was found to influence total cholesterol levels. J. Clin. Lab. Anal. 21:375–381, 2007. © 2007 Wiley‐Liss, Inc.

Keywords: apo B‐100, apo E, FH, hepatic lipase, LDL receptor, mutations, polymorphisms

REFERENCES

  • 1. Ashavaid TF, Todur SP, Dherai SP. Health status of Indian population—current scenario. J Assoc Physicians India 2004;52:363–369. [PubMed] [Google Scholar]
  • 2. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992;1:445–466. [DOI] [PubMed] [Google Scholar]
  • 3. Innerarity TL, Mahley RW, Weisgraber KH, et al. Familial defective apoB‐100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res 1990;31:1337–1349. [PubMed] [Google Scholar]
  • 4. Siest G, Pillot T, Regis‐Bailly A, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995;41:1068–1086. [PubMed] [Google Scholar]
  • 5. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 1998;18:1723–1729. [DOI] [PubMed] [Google Scholar]
  • 6. Kotze MJ, Langenhoven E, Peeters AV, Theart L, Osthuizen OJJ. Detection of two point mutations causing familial defective apolipoprotein B‐100 by heteroduplex analysis. Mol Cell Probes 1994;8:513–518. [DOI] [PubMed] [Google Scholar]
  • 7. Heath KE, Gahan M, Whitall RA, Humphries SE. Low‐density lipoprotein receptor gene (LDLR) world‐wide website in familial hypercholesterolemia: update, new features and mutation analysis. Atherosclerosis 2001;154:243–246. [DOI] [PubMed] [Google Scholar]
  • 8. Kotze MJ, Loubser O, Thiart R, et al. CpG hotspot mutations at the LDL receptor locus is a frequent cause of familial hypercholesterolemia among South African Indians. Clin Genet 1997;51:394–398. [DOI] [PubMed] [Google Scholar]
  • 9. Soutar AK, Knight BL, Patel DD. Identification of a point mutation in growth factor repeat of low density lipoprotein receptor gene in patient with homozygous familial hypercholesterolemia that effects ligand binding and intracellular movement of receptors. Proc Natl Acad Sci USA 1989;86:4166–4170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Ashavaid TF, Todur SP, Nair KG. Apolipoprotein E4 polymorphism as a risk factor coronary heart disease among Indian subjects. Indian J Clin Biochem 2002;17:83–93. (http://medind.nic.in/imvw129.html) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Zambon A, Deeb SS, Brown BG, Hokanson JE. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid‐lowering treatment. Circulation 2001;103:792–798. [DOI] [PubMed] [Google Scholar]
  • 12. Scientific Steering Committee on behalf of the Simon Broome Register Group . Risk of coronary heart disease in familial hypercholesterolemia. Br Med J 1991;303:893–896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin Chem 1972;18:499–502. [PubMed] [Google Scholar]
  • 14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Kotze MJ, Theart L, Callis M, Peeters AV, Thiart R, Langenhoven E. Non‐radioactive multiplex PCR screening strategy for the simultaneous detection of multiple low‐density lipoprotein gene mutations. PCR Methods Appl 1995;4:352–356. [DOI] [PubMed] [Google Scholar]
  • 16. Kim DS, Lee HS, Choi SI, Kim JJ, Suh SP. A modified amplification refractory mutation system for apolipoprotein E genotyping [Abstract]. Clin Chem 1999;45(Suppl):A17. [Google Scholar]
  • 17. Guerra R, Wang J, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 1997;94:4532–4537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Webb TC, Sun X‐M, McCarthy SN, et al. Characterization of mutations in the low density lipoprotein (LDL) receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom. J Lipid Res 1996;37:368–381. [PubMed] [Google Scholar]
  • 19. van der Westhuyzen DR, Coetzee GA, Demasius IPC, et al. Low density lipoprotein mutations in South African homozygous familial hypercholesterolemic patients. Arteriosclerosis 1984;4:238–247. [DOI] [PubMed] [Google Scholar]
  • 20. Mak YT, Zhang J, Chan YS, et al. Possible common mutations in the low density lipoprotein receptor gene in Chinese. Hum Mutat 1998;Suppl 1:S310–S313. [DOI] [PubMed] [Google Scholar]
  • 21. Ashavaid TF, Kondkar AA, Nair KG. Identification of two LDL receptor mutations causing familial hypercholesterolemia in Indian subjects. J Clin Lab Anal 2000;14:293–298. [DOI] [PubMed] [Google Scholar]
  • 22. Ehnholm C, Lukka M, Kuusi T, Nikkila E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227–235. [PubMed] [Google Scholar]
  • 23. Friedlander Y, Leitersdorf E. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia. Genet Epidemiol 1996;13:159–177. [DOI] [PubMed] [Google Scholar]
  • 24. Gylling H, Kuusi T, Vanhanen H, Miettinen TA. Apolipoprotein E phenotype and cholesterol metabolism in familial hypercholesterolemia. Atherosclerosis 1989;80:27–32. [DOI] [PubMed] [Google Scholar]
  • 25. Mozas P, Castillo S, Reyes G, et al. Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia. Am Heart J 2003;145:999–1005. [DOI] [PubMed] [Google Scholar]
  • 26. Eto M, Watanabe K, Chonan N, Ishii K. Familial hypercholesterolemia and apolipoprotein E4. Atherosclerosis 1988;72:123–128. [DOI] [PubMed] [Google Scholar]
  • 27. Couture P, Otvos JD, Cupples LA, et al. Association of the C‐514T polymorphism in the hepatic lipase gene with variations in the lipoprotein subclass profiles. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 2000;20:815–823. [DOI] [PubMed] [Google Scholar]
  • 28. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC. Hepatic lipase activity is lower in African American men than in those white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 1998;39:228–232. [PubMed] [Google Scholar]
  • 29. Tahvanainen E, Syvanne M, Frick MH, et al. Association of variations in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Investigators. J Clin Invest 1998;101:956–960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Allayee H, Dominguez KM, Aouizerat BE, et al. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia. J Lipid Res 2000;4:245–252. [PubMed] [Google Scholar]
  • 31. Mahaney MC, Blangero J, Rainwater DL, et al. A major locus influencing plasma high density lipoprotein cholesterol in the San Antonio Family Heart Study: segregation and linkage analyses. Arterioscler Thromb Vasc Biol 1995;15:1730–1739. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES